We describe a double in situ hybridization assay for the simultaneous detection of Herpes simplex virus (HSV) and cytomegalovirus (CMV) DNA in infected cell cultures using nonradioactive-labeled probes. This work used a biotinylated HSV DNA probe, which can be revealed by an avidin-biotin-peroxidase complex and a digoxigenin-labeled CMV DNA probe, visualized by anti-digoxigenin F(ab) fragments conjugated with alkaline phosphatase. Light microscopy visualization was achieved by the contrasting colors of appro-' Supported in part by Italian Ministry of Health, AIDS Project 1991, priate peroxidase and alkaline phosphatase reaction products (red and dark blue, respectively). The time required to perform the double hybridization assay was about 3 hr. This double hybridization assay proved to be sensitive, specific, and provided good resolving power. (JIfistochem Cytochem 40:421-425, 1992) KEY WORDS: Double hybridization; HSV/CMV DNA; Biotinylated and digoxigenin-labeled probes.
Introduction
In recent years there has been increasing interest in the application of in situ hybridization to the detection and identification of viral genomes in clinical specimens because of the clear specificity and potentially high sensitivity of t h i s technology (1, 23, 25, 28) . Moreover, the advances in antiviral chemotherapy, especially for herpes viruses, has made accurate and rapid viral diagnosis increasingly important.
Herpes szmplex virus (HSV) and cytomegalovirus (CMV) are members of the Herpesvirzdae family. These viruses can cause severe infections in neonates ( 2 9 3 ) and immunocompromised patients, such as transplant recipients, patients receiving therapy for neoplastic diseases (9,10), and patients with acquired immunodeficiency syndrome (AIDS) (3,27). The possibility of a double viral infection by HSV and CMV in these patients prompted us to develop a double in situ hybridization assay to simultaneously detect CMV DNA and HSV DNA in infected cell cultures.
In the last few years, several authors have successfully pursued double hybridization assays using both radioactive-labeled and nonisotopic probes (11) (12) (13) 20, 26) . This has proved very important in the fields of cytogenetics, oncology, and cell biology because of the increasing interest in the demonstration of multiple targets (nu-cleic acid sequences) in the same specimens. For simultaneous detection of CMV DNA and HSV DNA in infected cell cultures, in our work we used a biotinylated HSV DNA probe which can be visualized by an avidin-biotin-peroxidase complex, and a digoxigenin-labeled CMV DNA probe, visualized by anti-digoxigenin F(ab) fragments conjugated with alkaline phosphatase.
The biotinylated HSV DNA probe used in this work has been successfully employed by several researchers in the diagnosis of HSV infection using in situ hybridization, both in tissue samples and in infected cell cultures (2, 4, (6) (7) (8) 181 . Moreover, the digoxigeninlabeled CMV DNA probe constructed in our laboratory proved very specific and sensitive in the detection of CMV DNA with both in situ hybridization and dot-blot hybridization assay as previously described (8,21,22).
Materials and Methods
Cells and Viruses. Human embryo lung fibroblasts (HEL) were grown in Eagle's minimum essential medium supplemented with inactivated 10% fetal calf serum in the presence of 10 U of penicillin and 50 pg/ml of streptomycin. Cell monolayers were grown in Leighton tubes on pre-treated glass slides. Glass slide pre-treatments were performed as previously described (8).
The Towne strain of human CMV and a reference laboratory suain (BE80) of HSV 2 were used in the double hybridization assay. Moreover, two clinical samples of saliva from AIDS patients, positive at virus isolation for both HSV and CMV, were tested.
Virus-infected and mock-infected HEL monolayers were fixed at 24.48, 72, and 96 hr post infection (pi.) with 4% paraformaldehyde in phosphatebuffered saline (PBS; 0.15 M, pH 7.4) for 30 min. After fixation, cells were washed three times in PBS for 10 min each and then dehydrated with ethanol washes (30, 60, 80, 95, and 100%) for 5 min each. Cells were then air-dried and stored at 4'C. Viral Probes. The CMV DNA probe was constructed using the Towne CMV Xba I D-fragment (20 kilobase pairs) belonging to repeated regions of the CMV genome (16). The fragment was cloned in plasmid pACYC 184 and amplified in E. coli HB 101 (30) . Routine methods for the largescale preparation of plasmid were used (19) . Xba I CMV D-fragment was excised from the pACYC 184 vector and separated by electrophoresis in 0.6% low-temperature agarose gel. The CMV DNA D-fragment was then recovered from the gel using the Maniatis method (19) and processed for labeling. Probe labeling was carried out by incorporating digoxigenin-labeled deoxyuridine triphosphate (Dig-dUTP) (Boehringer; Mannheim, FRG) using the random-primed DNA labeling method developed by Feinberg and Vogelstein (5). Our CMV DNA probe was able to detect between 1-0.1 picograms of dotted homologous DNA. The CMV DNA probe could be stored at -20°C for at least 4 months with no decrease in its activity (8). The HSV Type I and Type I1 DNA probe, which is commercially available (Enzo Biochem; New York, NY), was prepared from a mixture of two sequences, each cloned into pBR322. These included two HSV Type 1 fragments of 3.0 and 8.0 KB pairs and one HSV Type I1 fragment of 16.0 KB pairs. The probe was biotinylated with the thymidine analogue >[N-(Nbiotinyl-~-aminocaproyl)-3-aminoallyl] deoxyuridine triphosphate. The resultant probe reacts with both serotypes of HSV.
Pre-treatment of Cell Monolayers. Cell monolayers were hydrated briefly in PBS and then placed in 0.02 N HC1 for 10 min. After three washes with PBS, cells were treated with 0.01% Triton X-100 in PBS for 2 min. After a further three washes with PBS, the cells were treated with pronase (Sigma; St Louis, MO) (0.5 mg/ml) in 0.05 M Tris-HCI buffer, pH 7.6, containing 5 mM EDTA for 10 min at room temperature. Then the cells were washed twice with PBS containing 2 mglml of glycine. Cell monolayers were treated with pancreatic RNAse (Sigma) (100 pglml) and T1 RNAse (Sigma) ( 5 pglml) in PBS for 1 hr at room temperature and then washed twice with PBS to remove RNAs. After these treatments, cell monolayers were postfixed with 4% paraformaldehyde in PBS and washed twice with PBS containing 2 mglml of glycine. Cells were then dehydrated by ethanol washes (30, 60, 80, 95, and 100%) . Double Hybridization Reaction. Dehydrated cell monolayers were overlaid with 20 pl of the hybridization mixture. The hybridization mixture consisted of 50% deionized formamide, 10% dextran sulfate, 250 nglpl of carrier calf thymus DNA, 20 nglpl of digoxigenin-labeled CMV-DNA probe, and 24 n g l d of biotin-labeled HSV-DNA probe in 2 x SSC (1 x SSC is 0.15 M sodium chloride plus 0.015 sodium citrate, pH 7.0). A clean, sterile glass coverslip was then applied, with care being taken to prevent air bubbles. The edges of the coverslip were sealed with rubber cement to prevent loss of the mixture during denaturation and hybridization. Cell samples and the hybriduation mixture containing the labeled probes were simultaneously denatured by heating in a 92°C water bath for 4-5 min. and were then put to hybridize at room temperature (RT) for 30 min. After hybridization, the coverslips were carefully removed and probe wash solution (50% formamide, 0.1 x PBS. pH 7.0) was applied at RT for 5 min. The slides were then rinsed with PES and shaken to remove excess buffer.
Detection of Hybridized Probes. Slides were briefly washed in 100 mM Tris-HC1 buffer, pH 7.5, containing 150 mM NaC1. The blocking reagent (Boehringer) was applied to cell monolayers for 30 min at RT. After two washings for 2 min in Tris-HC1 buffer, cells were incubated for 30 min with polyclonal anti-digoxigenin F(ab) fragments conjugated to alkaline phosphatase, diluted 1:SooO in Tris-HCI buffer. Unbound antibody was removed by two 15-min washes with Tris-HC1 buffer. Cell monolayers were then incubated with avidin-biotin-horseradish peroxidase for 20 min at RT, then rinsed in PBS. The slides were then equilibrated for 2 min with equilibra-tion buffer (EB) (100 mM Tris-HCI. 100 mM NaCI, 50 mM MgC12, pH 9.5); then the alkaline phosphatase substrate was added. The alkaline phosphatase substrate consisted of 45 11 of Solution A [75 mglml of nitroblue tetrazolium salt (NBT) in 70% dimethylformamide] and 35 pl of Solution B [75 mglml of 5-bromo-4-chlor0, 3-indolylphosphate (BCIP), toluidine salt in dimethylformamide] plus 920 pl of equilibration buffer. The development of a dark-blue precipitate at the enzyme site in positive cells was monitored by microscopic examination. The reaction was usually complete after about 15 min. Cell monolayers were washed for 5 min with TE buffer (10 mM Tris-HCI, 1 mM EDTA, pH 8); then the peroxidase substrate solution 12 mg of 3-amino-9-ethylcarbazole (EAC) in 1.2 ml of dimethylsulfoxide plus 0.8 pl of 30% hydrogen peroxide in 10 ml of 0.02 M acetate buffer, pH 3.01 was added. The reaction was stopped by washing in distilled water after about 10 min, when the cell displayed characteristic red nuclear staining by microscopic examination. Cell monolayers were then mounted with glycerol gelatin (Merck; Darmstadt, FRG).
Results
As a first proof to determine the sensitivity and specificity of the probes, we made single hybridizations with one-color staining with either CMV or HSV DNA probe on cell cultures infected with clinical specimens positive both for CMV and HSV. Using the HSV biotinylated probe, visualized with an avidin-biotin-peroxidase complex, a red precipitate deposited almost exclusively in the nuclei of infected cells was clearly visible in infected monolayers fixed at 24 hr pi. Using the digoxigenin-labeled CMV probe, which is visualized by anti-digoxigenin F(ab) fragments labeled with alkaline phosphatase, a dark-blue reaction product was observed in the nuclei of infected cells starting at 48 hr p.i.
In the double hybridization assay for CMV and HSV DNA, a double positive reaction with CMV-infected cells stained in dark blue and HSV-infected cells stained in red was observed in all cell cultures fixed from 48 hours pi. Positive signals were clearly demonstrated as nuclear staining and the red reaction obtained with the HSV DNA probe contrasted well with the dark-blue color obtained using the CMV DNA probe. Figure 1 shows a representative field obtained with infected cell cultures hybridized with a mixture of HSV and CMV DNA probes. In Figure 2 , two syncytial giant cells positive both for HSV DNA and CMV DNA can be observed. The comparison of the signal visualization and intensity of single staining and double staining experiments showed no difference. Moreover, the color of enzyme reaction product was identical to that obtained in single stainings. In our double hybridization assay, although the enzymatic reaction for alkaline phosphatase was usually performed before that of peroxidase, identical results were obtained when the substrate reaction sequence was reversed.
The specificity of the double hybridization signals was also confirmed by the following control experiments: (a) No cytochemical signal was observed when HSV-infected cells were single-hybridized with digoxigenin-labeled CMV DNA probe and, similarly, no signal was detected after hybridization of CMV-infected cells with biotinylated HSV DNA probe. (b) CMV-and HSV-infected cells were completely unstained after double hybridization with unlabeled CMV and HSV DNA probes. (c) No labeling was noted when mockinfected cells were double-hybridized with labeled CMV and HSV DNA probes.
Discussion
Our study describes a double hybridization assay for the simultaneous detection of HSV and CMV DNA in infected cell cultures, using a biotinylated HSV DNA probe and a digoxigenin-labeled CMV DNA probe. At present, several possibilities are available to label nucleic acids, either radioactively or non-radioactively, combinations of which can be used for double in situ hybridization (11, 12, 13, 20, 26) . Double hybridization using one or both radioactively labeled probes has sheral drawbacks: it is time consuming, the probes have a short shelf life, it is expensive, and it involves disposal and personnel safety problems. For non-radioactive double in situ hybridization, on the other hand, the combination of cytochemically detectable biotinylated and haptenized nucleic acid probes has the great advantage of excellent topological resolution, short processing time, and stability of the probes.
The digoxigenin-labeled CMY DNA probe used in our work, was constructed from the Xba I D-fragment of CMV, excised from the pACYC 184 vector. This avoided hybridization of vector sequences present in dlfferent probes. In fact, if an insert fragment with flanking vector sequences hybridizes with the target, a network of vector sequences may be formed on the primary hybridization site (2 5). Using probes constructed from excised viral fragments, no mixed colors, indicating network formation, were observed in our experiments. Moreover, in our work the detection systems of the hybridized probes consisted of an avidin-biotin-peroxidase com-plex and of anti-digoxigenin F(ab) fragments conjugated with alkaline phosphatase. This avoided any possible aspecific reactions due to the binding of F(c) fragments of antibody to F(c) receptors which are present in both HSV and CMV infected cells (14,U).
Although the hybridization of our probes with specific CMV and HSV mRNAs would have amplified the hybridization signals, in our assay infected cells were treated with RNAse as a DNA-DNAspecific hybridization was desired. As a first proof to determine the sensitivity and specificity of the probes, we made single hybridizations with one-color staining with either CMV or HSV DNA probe. Our results confirmed previous reports on these methods (4,8,17) .
Our double hybridization assay proved highly specific, since no cytochemical signals were observed in mock-infected cells; CMV DNA probe did not crossreact with HSV DNA, and similarly, the HSV DNA probe did not hybridize with CMV DNA.
The time required to complete our double hybridization assay for the simultaneous detection of CMV and HSV DNA in infected cells was about 3 hr. The rapid results obtained with DNA probes can direct prompt and appropriate anti-viral therapy in cases of severe CMV or HSV infections.
Our double hybridization assay was performed on infected cell monolayers, but it can presumably be applied on tissue sections, since our digoxigenin-labeled CMV probe and the biotinylated HSV probe used in this work were successfully used in single hybridization assays on frozen or formalin-fixed, paraffin-embedded tissue sections (2,21). Our results indicate that the double hybridization assay described may offer a valuable tool for the diagnosis of dual viral infection and even for the study of possible viral interactions at the single-cell level. 18.
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